Sanginita Chemicals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
SANGINITA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanginita Chemicals Limited reported its Q3 FY26 (October–December 2025) unaudited results with revenue from operations falling to ₹4,347.40 lakhs, down about 29% from ₹6,153.83 lakhs in the same quarter last year. The nine-month revenue also declined roughly 26% YoY to ₹13,348.64 lakhs (vs ₹17,982.87 lakhs). The company swung from a small profit of ₹14.08 lakhs in Q3 FY25 to a loss of ₹278.24 lakhs in Q3 FY26, with the nine-month loss widening to ₹335.24 lakhs (vs a profit of ₹67.22 lakhs). Loss per share stood at ₹1.07 for the quarter and ₹1.29 for nine months, against a positive ₹0.05 and ₹0.26 respectively last year. The statutory auditor's limited review report is clean, with no qualifications or emphasis-of-matter issues flagged.
Sharp revenue contraction coupled with a swing into losses is a negative signal for shareholders — it points to both demand weakness and margin pressure, which could weigh on the stock price in the near term until the company demonstrates a turnaround in volumes and profitability.